The role of CREB in AD pathology has been highlighted by the observation that pCREB is decreased in the nuclear fraction of postmortem prefrontal cortex (PFC) of individuals with AD, as compared to age‐matched, cognitively normal controls (Bartolotti et al., 2016a,b). The gene discussed is CREB1; the disease is Alzheimer disease.